[MAXIS] QoQ Quarter Result on 31-Dec-2022 [#4]

Stock
[MAXIS] MAXIS BERHAD
Announcement Date
23-Feb-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Dec-2022 [#4]
Profit Trend
QoQ- -23.81%
YoY- -16.96%
Quarter Report
Latest QR
Upcoming QR
MAXIS's Result
MAXIS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 2,442,000 2,470,000 2,526,000 2,554,000 2,405,000 2,424,000 2,406,000 0.99%
PBT 384,000 453,000 429,000 409,000 470,000 500,000 432,000 -7.54%
Tax -97,000 -124,000 -109,000 -170,000 -155,000 -171,000 -134,000 -19.36%
NP 287,000 329,000 320,000 239,000 315,000 329,000 298,000 -2.47%
-
NP to SH 287,000 330,000 320,000 240,000 315,000 329,000 298,000 -2.47%
-
Tax Rate 25.26% 27.37% 25.41% 41.56% 32.98% 34.20% 31.02% -
Total Cost 2,155,000 2,141,000 2,206,000 2,315,000 2,090,000 2,095,000 2,108,000 1.47%
-
Net Worth 6,030,699 6,029,214 6,264,119 6,342,420 6,499,023 6,574,067 6,652,330 -6.32%
Dividend
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Div 313,283 313,205 313,205 391,507 391,507 391,313 391,313 -13.76%
Div Payout % 109.16% 94.91% 97.88% 163.13% 124.29% 118.94% 131.31% -
Equity
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Net Worth 6,030,699 6,029,214 6,264,119 6,342,420 6,499,023 6,574,067 6,652,330 -6.32%
NOSH 7,832,077 7,830,148 7,830,148 7,830,148 7,830,148 7,826,271 7,826,271 0.04%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 11.75% 13.32% 12.67% 9.36% 13.10% 13.57% 12.39% -
ROE 4.76% 5.47% 5.11% 3.78% 4.85% 5.00% 4.48% -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 31.18 31.54 32.26 32.62 30.71 30.97 30.74 0.95%
EPS 3.70 4.20 4.10 3.10 4.00 4.20 3.80 -1.76%
DPS 4.00 4.00 4.00 5.00 5.00 5.00 5.00 -13.81%
NAPS 0.77 0.77 0.80 0.81 0.83 0.84 0.85 -6.37%
Adjusted Per Share Value based on latest NOSH - 7,830,148
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
RPS 31.18 31.53 32.25 32.61 30.70 30.95 30.72 0.99%
EPS 3.66 4.21 4.09 3.06 4.02 4.20 3.80 -2.46%
DPS 4.00 4.00 4.00 5.00 5.00 5.00 5.00 -13.81%
NAPS 0.7699 0.7697 0.7997 0.8097 0.8297 0.8393 0.8493 -6.32%
Price Multiplier on Financial Quarter End Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 -
Price 4.04 4.10 4.13 3.84 3.51 3.30 3.93 -
P/RPS 12.96 13.00 12.80 11.77 11.43 10.65 12.78 0.93%
P/EPS 110.25 97.28 101.06 125.28 87.25 78.50 103.21 4.49%
EY 0.91 1.03 0.99 0.80 1.15 1.27 0.97 -4.16%
DY 0.99 0.98 0.97 1.30 1.42 1.52 1.27 -15.28%
P/NAPS 5.25 5.32 5.16 4.74 4.23 3.93 4.62 8.88%
Price Multiplier on Announcement Date
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Date 10/11/23 09/08/23 19/05/23 23/02/23 04/11/22 28/07/22 28/04/22 -
Price 4.03 3.98 4.36 4.06 3.79 3.62 3.81 -
P/RPS 12.93 12.62 13.52 12.45 12.34 11.69 12.39 2.88%
P/EPS 109.98 94.44 106.69 132.46 94.21 86.11 100.06 6.49%
EY 0.91 1.06 0.94 0.75 1.06 1.16 1.00 -6.08%
DY 0.99 1.01 0.92 1.23 1.32 1.38 1.31 -17.01%
P/NAPS 5.23 5.17 5.45 5.01 4.57 4.31 4.48 10.86%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment